A Study to Test the Safety and Efficacy of MK0249 in Patients With ADHD (0249-018)(COMPLETED)

Clinical trial NCT00475735 · COMPLETED

Trial details

NCT number: NCT00475735
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Attention-Deficit/Hyperactivity Disorder (ADHD)

Start date: 2007-07-01
Primary completion: 2008-04-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.